Gout Arthritis
13
4
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
23%
3 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (13)
A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment
Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity
HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness
Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares
An Exploratory Clinical Study on the Protective Effect of Cycling on the Ankle Joint in Gout
Nurse-Led Telehealth for Gout
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis
A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.
A Study to Investigate the Pharmacokinetic/Pharmacodynamic Characteristics of IBI128(A New Xanthine Oxidase Inhibitor)
NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares
Evaluation and Characterisation of Microplastics and Nanoplastics in Joint Synovial Liquid
The Relationship Between Cold Water Immersion and the Progression in Gout Arthritis